Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Completed · Phase 3
Conditions studied: Atopic Dermatitis
In brief
This is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis. It will last up to 33 months.
Key facts
- Study ID
- NCT04392154
- Run by
- Eli Lilly and Company
- People needed
- 1153
- Starts
- 2020-06-15
- Expected to finish
- 2025-04-22
- Last updated by the study team
- 2025-11-05
Who can join
Age: 12 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Clinical Research Center of Alabama- Birmingham — Birmingham, Alabama, United States
- Investigate MD — Scottsdale, Arizona, United States
- Johnson Dermatology — Fort Smith, Arkansas, United States
- Burke Pharmaceutical Research — Hot Springs, Arkansas, United States
- Arkansas Research Trials — North Little Rock, Arkansas, United States
- Northwest Arkansas Clinical Trials Center — Rogers, Arkansas, United States
- Orange County Research Institute — Anaheim, California, United States
- Bakersfield Dermatology and Skin Cancer Medical Group — Bakersfield, California, United States
- Wallace Medical Group, Inc. — Beverly Hills, California, United States
- Hope Clinical Research, Inc. — Canoga Park, California, United States
- California Dermatology & Clinical Research Institute — Encinitas, California, United States
- First OC Dermatology — Fountain Valley, California, United States
- MD Studies — Fountain Valley, California, United States
- Center For Dermatology Clinical Research, Inc. — Fremont, California, United States
- Axon Clinical Research — Inglewood, California, United States
- Sunwise Clinical Research — Lafayette, California, United States
- Avance Clinical Trials Inc — Laguna Niguel, California, United States
- California Allergy and Asthma Medical Group + Research Center — Los Angeles, California, United States
- Keck School of Medicine University of Southern California — Los Angeles, California, United States
- Dermatology Research Associates — Los Angeles, California, United States
- LA Universal Research Center, INC — Los Angeles, California, United States
- Ablon Skin Institute and Research Center — Manhattan Beach, California, United States
- Dermatology Clinical Trials — Newport Beach, California, United States
- Cura Clinical Research — Palmdale, California, United States
- Pinnacle Research Group, LLC — Anniston, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.